See also this year's filing and all EDGAR filings for this company.
PDF Report 0001053369_2026_Elite_Pharmaceuticals_INC_NV.pdf
Logs
Graph
Absolute values for 0001053369, Elite Pharmaceuticals INC NV
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 57,739,147 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,637,802 |
| 2 | PropertyPlantAndEquipmentNet | 10,327,245 |
| 3 | remainder_Assets | 22,683,283 |
| 4 | LiabilitiesCurrent | 11,840,435 |
| 5 | LiabilitiesNoncurrent | 31,032,013 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 82,472,555 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,430,406 |
| 9 | ResearchAndDevelopmentExpense | 8,174,395 |
| 10 | remainder_Expenses | -18,083,467 |
| 11 | remainder_Revenues | 184,746,210 |
| 12 | remainder_NetIncome | -16,231,647 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 96,387,477 |
| 1 | Liabilities | 42,872,448 |
| 2 | Expenses | 85,993,889 |
| 3 | Revenues | 184,746,210 |
| 4 | StockholdersEquity | 53,515,029 |
| 5 | NetIncome | 82,520,674 |
| 6 | ComprehensiveNetIncome | 82,520,674 |
| 7 | BaseVar | 213,115,836 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.86 |
| 9 | EconomicCapitalRatio | 3.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
